FDA Adds Two Device Shortages: Angiographic Syringes and Breast Biopsy Needles

The FDA updated its medical device shortage list on March 13, 2026, adding angiographic control syringes with rotating adapters and stereotactic breast biopsy needles. For patients and families, the main takeaway is practical: a shortage is not the same thing as a recall, but it can still affect whether a procedure happens on time and which device a clinic or hospital uses.

Because both devices are used in procedures that can be time-sensitive, even a supply disruption may create scheduling challenges or require a substitute device when one is clinically appropriate.

What the FDA updated

On March 13, the FDA added two device types to its shortage list and updated the status of shortages already under review. The shortage list is meant to improve transparency about supply problems, but a device appearing on the list does not necessarily mean patient care has already been disrupted.

What these devices are used for

Angiographic control syringes with rotating adapters are used in some imaging and vascular procedures. Stereotactic breast biopsy needles are used to collect tissue samples guided by breast imaging. Because these devices support scheduled procedures, shortages can matter quickly if a facility has limited stock or no easy substitute.

Why shortages matter for patient care

FDA shortage reporting is a patient-safety issue as well as a supply issue. When a device is hard to obtain, hospitals and clinics may need to conserve stock, move cases to another day, or switch to a different product if that is safe and available. CDC has also noted in the context of supply disruptions that shortages can affect diagnosis and patient management, which helps explain why clear communication matters for patients and caregivers.

How a shortage differs from a recall or safety alert

A shortage means a device may be hard to obtain in the expected amount or on the expected timeline. A recall, market withdrawal, or safety alert is different and usually involves a product defect, contamination concern, labeling issue, or other safety problem.

That distinction matters. A device can be in short supply without being unsafe, and a device can be recalled even if it is not in shortage.

What clinicians and facilities may do

FDA guidance for providers and device stakeholders emphasizes preparation and communication. In practice, facilities may conserve existing stock, use an alternative device when clinically appropriate, reschedule non-urgent procedures, or adjust inventory across locations.

For hospitals, ambulatory surgery centers, and clinics, the most useful steps are often operational: checking inventory early, talking with distributors, identifying backup products, and telling patients promptly if timing changes.

What patients and families can ask

If you have a procedure coming up, you can ask whether the device used for your procedure is on a shortage list and whether that could affect timing. You can also ask whether your clinician expects to use the same device or a substitute that serves the same purpose.

If your appointment is delayed, ask whether the delay is due to supply, staffing, insurance authorization, or another issue. That can help you understand whether the change is temporary or whether you need a new plan.

What remains unknown

The FDA gives estimated shortage durations, but those estimates can change. The March 13 update reflects the information available at the time, not a guarantee about when supply will fully normalize.

What readers should watch next is whether the listed devices move off shortage sooner than expected, whether more devices are added, and whether hospitals begin issuing broader substitutions or scheduling changes.

Bottom line

For most readers, the practical message is simple: if you have an upcoming procedure, do not assume it will be changed, but do ask whether device supply could affect your appointment. Shortages are often manageable, and they are easier on patients when clinicians and facilities communicate early.

Sources

Editorial note: Weence articles are researched from cited public-health, medical, regulatory, journal, and reputable news sources and may be drafted with AI assistance. They are checked for source support, clarity, and safety guardrails before publication.

This article is for general informational purposes only and is not medical advice. Research findings can be early or incomplete, and health guidance can change. Always talk with a qualified healthcare professional about personal symptoms, diagnosis, medications, vaccines, screenings, or treatment decisions. If you think you may have a medical emergency, call emergency services right away.